| abstract |
The present invention provides a compound of formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein all variables are as defined herein. These compounds are selective ROCK inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and methods of using them for the treatment of cardiovascular, smooth muscle, oncological, neuropathological, autoimmune, fibrotic and/or inflammatory disorders. |